|
|
|
|
A more recent version of this article appeared on September 1, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 16, 2007
Revised on June 18, 2007
Accepted on June 25, 2007
EF1 Proteins in Epithelial-Mesenchymal Transition Induced by TGF-
Department of Molecular Pathology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
Monitoring Editor: Carl-Henrik Heldin
Epithelial-mesenchymal transition (EMT), a crucial event in cancer progression and embryonic development, is induced by transforming growth factor (TGF)-
in mouse mammary NMuMG epithelial cells. Id proteins have previously been reported to inhibit major features of TGF-
-induced EMT. In this study, we show that expression of the
EF1 family proteins,
EF1 (ZEB1) and SIP1, is gradually increased by TGF-
with expression profiles reciprocal to that of E-cadherin. SIP1 and
EF1 each dramatically down-regulated the transcription of E-cadherin in NMuMG cells through direct binding to the E-cadherin promoter. Silencing of the expression of both SIP1 and
EF1, but not either alone, completely abolished TGF-
-induced E-cadherin repression. However, expression of mesenchymal markers, including fibronectin, N-cadherin, and vimentin, was not affected by knock-down of SIP1 and
EF1. TGF-
induced the expression of Ets1, which in turn activated
EF1 promoter activity. Moreover, upregulation of SIP1 and
EF1 expression by TGF-
was suppressed by knock-down of Ets1 expression. In addition, Id2 suppressed the TGF-
- and Ets1-induced upregulation of
EF1. Taken together, these findings suggest that the
EF1 family proteins, SIP1 and
EF1, are necessary, but not sufficient, for TGF-
-induced EMT, and that Ets1 induced by TGF-
may function as an upstream transcriptional regulator of SIP1 and
EF1.
This article has been cited by other articles:
![]() |
S.-M. Park, A. B. Gaur, E. Lengyel, and M. E. Peter The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 Genes & Dev., April 1, 2008; 22(7): 894 - 907. [Abstract] [Full Text] [PDF] |
||||